Thursday Feb 9 | BioSpace
OptiNose AS Announces First Patient Enrolled in Phase III Study of...
OptiNose AS Announces First Patient Enrolled in Phase III Study of Sumatriptan Powder Delivered Intranasally with Innovative Bi-directional Device YARDLEY, Pa.-- --The first patients have been successfully enrolled in a phase III study involving the intranasal delivery of sumatriptan powder using the OptiNose bi-directional technology.
Jim assembled an experienced management team and Scientific Advisory Board to progress lasmiditan through clinical development to become a Phase 3-ready compound.
With bated breath, companies await approval for inhalable drugs
The drug inhaler has become a medical mainstay for many people with asthma, cystic fibrosis and chronic obstructive pulmonary disease.
Small Pharma With Big Compounds: Final Dance With The FDA
Biotechnology companies spend an extraordinary amount of resources-capital, time, and personnel- to get to this point, a final dance with the FDA seeking drug approval.
Today in America Reviews The Latest In Headache Treatments with Migraine Treatment Centers
Today in America reviews effective new migraine treatment by a Texas based group of medical professionals dedicated to the treatment of migraines.
Migraine drug taken through the nose being tested
The Food and Drug Administration has granted OptiNose Inc. approval to initiate phase-III testing of an acute migraine headache treatment.
Allergan 4th-quarter profit, eye drug sales rise
The company's forecast for 2012 was lower than anticipated, sending its shares down as much as 2.8 percent, although some analysts consider the outlook conservative.
These days, thousands and thousands of Americans are struggling from migraine headaches, and it is listed as a single of the most commonly cited good reasons for missing operate.
Nautilus Neurosciences, Inc. Announces New Patent Issued
Additionally, methods are also provided for treating symptoms that often accompany migraine and acute pain such as photophobia, phonophobia, nausea and vomiting.
UPDATE 1-Impax Labs licenses Astrazeneca's migraine drug in US
Impax Laboratories said it has licensed AstraZeneca's migraine treatment, Zomig, in the United States and will pay quarterly payments totaling $130 million during 2012 to the British drugmaker.
'I Wanted To Live:' New Depression Drugs Offer Hope For Toughest Cases
Chris Stephens, 28, has been battling depression all of his life, at home, in Concord, Ca., on Jan.
Treating Violence: New Antidotes
A friend who works at a psychiatric hospital told me that one evening several patients organized a rebellion and attempted to escape the building by use of force.
Buying Map Pharmaceuticals Ahead Of FDA Decision
In the research for my most recent piece on Biotech Buyouts I uncovered a list of attractive smaller bio/pharma companies that were developing compelling new drugs.
Top 10 Migraine and Headache Questions, 1/27/12
Do you have questions about headaches or Migraines? Many of our readers do, and each week, and Dr.
Migraine and cortisone injections
I'm a bit past middle age and sometimes get cortisone injections in my knees because of arthritis.
Teva Partnership And Pipeline Potential: Why Antares Is A Buy
The failure of the Libi-Gel trial rocked the stock of Antares and caused it to drop from around $2.62 to $1.67, with a subsequent recovery to $2.40. I think that this reaction failed to recognize the broad potential of the Antares product line beyond Libi-Gel. In particular, I think that the market is not giving sufficient value to Antares' ... (more)
I also make hot compresses at home, but with rice in a long sock. Same method: microwave for a minute or two to enjoy around 10 minutes of heat.
Can migraines change? I have had migraines since I was a kid. I always have a aura for about 20 min before the pain starts.
NuPathe Announces Allowance of Additional U.S. Patent Application for Its Migraine Patch
Given this action, NuPathe expects the patent to issue within the next few months.
UBM Medica's ConsultantLive Offers Migraine Diagnostic Help for Clinicians
With the goal of helping clinicians overcome diagnostic pitfalls - while also keeping them abreast of current treatment approaches and regimens - ConsultantLive recently launched its topic center on migraines.
Also on Topix